Stock Soars 4% After Torrent Acquires Controlling Stake in JB Pharma

As on 30 Jun 2025, share prices of

surged up to 4% in morning trade after announced signing definitive agreements to acquire a controlling stake in JB Chemicals & Pharmaceuticals () from KKR, valuing the deal at ₹25,689 crore. This landmark transaction will be followed by a merger of the two entities, propelling Torrent to become India’s second most valuable pharmaceutical company. The deal marks the second-largest acquisition in the Indian pharma space, trailing only Sun Pharma’s ₹29,000 crore buyout of Ranbaxy in 2015. The market welcomed the move, viewing it as a strategic push to expand Torrent's footprint and product portfolio. Analysts see strong synergies and potential value unlocking from the consolidation in the competitive pharma landscape. Disclaimer: This post is intended solely for informational purposes and should not be construed as a recommendation to buy, sell, or hold any security. Investors are advised to consult their certified financial advisor before making any investment decisions. Investments in the securities market are subject to market risks. Please read all relevant offer documents and disclosures carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide assurance of returns to investors. The securities and charts quoted herein, if any, are purely illustrative and are not to be interpreted as recommendatory. Past performance is not indicative of future results.